A Form 4 filed on November 6, 2026 discloses that Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., acquired 131.982 units of phantom stock on November 5, 2026 under the company's deferred compensation plan.

Key Highlights

  • Reporting person: Kyle Malady, identified in the filing as EVP and Group CEO-VZ Business at Verizon Communications Inc. (NYSE:VZ).
  • Transaction: Acquisition (code A) of 131.982 units of phantom stock (unitized) on November 5, 2026, held indirectly through a deferred compensation plan.
  • Phantom stock price: The underlying common stock price recorded in the filing is $13.17 per share.
  • Post-transaction holdings: Malady beneficially owned 431,514.187 units of phantom stock following the transaction, held indirectly by deferred compensation plan.
  • Dividend reinvestment: According to the filing, the total includes phantom stock acquired through dividend reinvestment.
  • Settlement terms: The filing states each share of phantom stock "is the economic equivalent of a portion of one share of common stock and is settled in cash," becoming payable upon events established by the reporting person in accordance with the deferred compensation plan.

Malady's Phantom Stock Acquisition Under Verizon Deferred Compensation Plan

According to the Form 4 filing, Kyle Malady, serving as EVP and Group CEO-VZ Business at Verizon Communications Inc., acquired 131.982 units of phantom stock on November 5, 2026. The acquisition is classified under transaction code A (acquired) and is held indirectly through the Verizon deferred compensation plan. The filing records an associated common stock price of $13.17 per share for the 38 shares of common stock referenced in the derivative security table.

The filing explains that each share of phantom stock "is the economic equivalent of a portion of one share of common stock and is settled in cash." The phantom stock units become payable upon events established by Malady in accordance with the deferred compensation plan. No direct ownership of common shares is reported in connection with this transaction.

Following the reported transaction, Malady's total beneficial ownership of phantom stock (unitized) stands at 431,514.187 units, held indirectly through the deferred compensation plan. The filing notes that this total includes phantom stock acquired through dividend reinvestment. The Form 4 was signed by Evgeniya Berezkina as attorney-in-fact for Kyle Malady and filed on November 6, 2026.

What Was Disclosed

The filing reports a single acquisition of 131.982 phantom stock units by Kyle Malady on November 5, 2026, under Verizon's deferred compensation plan, bringing total indirect beneficial ownership to 431,514.187 units. The phantom stock is cash-settled and linked to common stock value.